Crescita Therapeutics Inc. (CRRTF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 02:14PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.15M |
| Enterprise value | 199.06k |
| Trailing P/E | 23.38 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.51 |
| Price/book (mrq) | 0.45 |
| Enterprise value/revenue | 0.02 |
| Enterprise value/EBITDA | 4.46 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -35.56% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 0.5500 |
| 52-week low 3 | 0.2500 |
| 50-day moving average 3 | 0.3202 |
| 200-day moving average 3 | 0.3714 |
Share statistics
| Avg vol (3-month) 3 | 25 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 19.54M |
| Implied shares outstanding 6 | 19.67M |
| Float 8 | 17.2M |
| % held by insiders 1 | 10.71% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CAD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -13.05% |
| Operating margin (ttm) | -14.63% |
Management effectiveness
| Return on assets (ttm) | -5.90% |
| Return on equity (ttm) | -12.00% |
Income statement
| Revenue (ttm) | 17.92M |
| Revenue per share (ttm) | 0.89 |
| Quarterly revenue growth (yoy) | 8.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.34M |
| Net income avi to common (ttm) | -2.34M |
| Diluted EPS (ttm) | -0.0700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 9.53M |
| Total cash per share (mrq) | 0.49 |
| Total debt (mrq) | 1.15M |
| Total debt/equity (mrq) | 6.32% |
| Current ratio (mrq) | 3.59 |
| Book value per share (mrq) | 0.93 |
Cash flow statement
| Operating cash flow (ttm) | 323k |
| Levered free cash flow (ttm) | 502.12k |
© 2024 Yahoo. All rights reserved.